Novel Regimens in COVID-19 Treatment

Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

COVID Corona Virus Infection Coronaviridae Infections Coronavirus Infections Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Sherief Abd-Elsalam, Tanta, Egypt

About this study

Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019. Some studies demonstrated the efficacy of combined regimen of nitazoxanide and azithromycin or ivermectin and chloroquine.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with COVID-19 infection

Exclusion criteria

Allergy or contraindication to the drugs.

Treatment and study plan

Nitazoxanide

Drug

Nitazoxanide

Other names: Parazoxanide, Nanazoxid

Primary outcomes

Number of patients with virological cure

Time frame: 6 months

the number of patients with virological cure

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

Nitazoxanide in Treatment of COVID-19

Important dates

Study start: 2020
Primary completion: 2030
Study completion: 2030
First posted: May 11, 2020
Registry last updated: Dec 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting